Jeff Brown and Brownstone Research just launched a new marketing campaign “Executive Confession” for The Near Future Report, where Jeff talks about a revolutionary medical breakthrough that will grow 152% to more than $3 trillion globally in a few years.
Continue reading to find out what’s the company that stands behind this new technology and what’s Jeff Brown’s #1 Precision Medicine Stock of the 2020s…
Click here to learn more about Jeff Brown’s #1 Precision Medicine Stock of the 2020s
What Is Jeff Brown’s Executive Confession?
Jeff Brown is one of the most respected angel investors in Silicon Valley. He also has nearly 30 years of experience as an executive for some of the world’s most dominant technology firms.
And regular folks like you and I have had the chance to profit off of his experience the past few years.
His service produced annualized returns nearly 3X better than the S&P 500 between 2017 and 2020 overall.
In 2020 alone, Jeff did even better… annualized returns more than 4X better than the S&P 500.
He recommended the top S&P tech stocks in 2016, ’18, ’19, and ’20, based on return.
Now Jeff is backing a new technology that will impact the world…
And could impact investors…
For the next decade… Or even longer.
And this time, it’s personal.
This technology made a profound impact on Jeff’s life recently.
In fact, it may even have saved his life.
He recently made a personal confession about this technology…
And why he believes you need to get in on it… RIGHT NOW.
What Is Jeff Brown’s #1 Precision Medicine Stock of the 2020s?
According to a survey, 2 out of 3 Americans have never heard of this.
It’s a revolutionary medical breakthrough that will grow 152% to more than $3 trillion globally in a few years.
More importantly, it will radically change how we view medical care.
Millions of lives will be saved… as well as billions of dollars.
Jeff Brown, one of the most respected angel investors in Silicon Valley, took a close-up view of this technology.
To share his findings with you…
As well as to show you how you can learn how to profit from this technology, Jeff put together a special report called The #1 Precision Medicine Stock of the 2020s.
That’s where Jeff’s first precision medicine recommendation plays in.
This company is working hard to get the price of a full genetic sequencing under $100. It currently controls roughly 75% of the global market share. And it’s one of the most important players in the world of genetic sequencing.
Numerous companies and governments around the world are collecting data on full genomes of their population…
And many are using this company’s equipment to sequence patient DNA.
It’s so well-respected worldwide that the Food and Drug Administration (FDA) issued them what’s called an emergency use authorization (EUA) in the midst of the pandemic.
This was so its technology could be utilized in combating Covid-19.
Inside Jeff Brown’s The #1 Precision Medicine Stock of the 2020s report, you’ll get all the details on this company – not just the name and ticker symbol. This report is FREE when you subscribe for Jeff Brown’s tech newsletter The Near Future Report.
— RECOMMENDED —
Tech Expert: “S.A.V. Will Be Huge”
S.A.V. – that’s Elon Musk’s next big project that will shock the world.
And after months of research, this tech expert finally found the company that’s behind this new project.
This is all part of a $30 trillion trend that’s set to dominate this decade.
But hurry – all the big players are already getting in.
For example, Warren Buffett has already invested $15 billion in this trend… and said he’s ready to invest $15 billion more.
There’s no time to waste… click here now and get all the details
What Is The Near Future Report?
The Near Future Report is an elite tech investing newsletter where every month, Jeff publishes a new issue of The Near Future Report with a new way for you to potentially profit from the exploding tech market.
From his position as an angel investor and advisor to Silicon Valley startups across multiple types of tech, he learns about rapid advances in technology long before the rest of the world does.
And he can spot the signals of mass consumption on the horizon.
He’s not going to lecture you on technologies that are years away.
He’ll show you how you can make money on tech stocks right now.
In The Near Future Report, Jeff takes you behind the curtain to show you technologies on the verge of immediate adoption.
What’s Inside Jeff Brown’s Executive Confession Package?
Here’s everything that you’ll receive when you subscribe for The Near Future Report newsletter:
Jeff Brown’s “Executive Confession” Package
Instant access to Jeff Brown’s complete “Executive Confession” package including…
Bonus Report 1: The #1 Precision Medicine Stock of the 2020s: Why the FDA Just Fast-Tracked the “King of Genetic Sequencing”
Bonus Report 2: The Company Behind Cystic Fibrosis’ Demise
Bonus Report 3: Jeff Brown’s #1 Stock “Behind” Quantum Computing’s Rise
Bonus Report 4: Jeff Brown’s #1 Gene Therapy Stock
12 Monthly Issues of The Near Future Report
Receive brand-new recommendations right in your inbox.
Past AND Future Reports
Get instant access to every special report and issue ever published and instant access to each new special report Jeff Brown publish at no extra charge. That alone is priceless.
Members-Only Portfolio Access 24/7
At any time, you can open up The Near Future Report model portfolio and track its performance.
Locked-In Discounted Renewal
The Near Future Report retails at $199. By joining today, you lock in a discounted renewal rate of just $129 – even if the price goes up.
Professional, U.S. Based Customer Service
You can call Brownstone Research Customer service any time Monday–Friday, 9 am–7 pm ET. Brownstone Research team of experienced agents can help you with almost anything. Please note: They cannot give any personalized investment advice.
— RECOMMENDED —
“Penny Trade” Pays Warren Buffett as Much as an Extraordinary 4,429%?
“Penny Trades” are cheap and explosive…
Warren Buffett grabbed 46 million of them for 1¢ a pop.
Right now, he’s up as much as a rare 4,429% on this trade.
But “Penny Trades” aren’t reserved for billionaires like Buffett.
Thanks to SEC loophole 30.52, you can play them in your brokerage account.
- One of these “Penny Trades” shot up 183% in one day…
- Penny Trades can pay far MORE than stocks…
- Our readers just saw a 19¢ trade shoot up as much as a rare 5,100%…
Here’s the No. 1 “Penny Trade” for RIGHT NOW
The Near Future Report Subscription Fee
You can one year of The Near Future Report for $49.
The Near Future Report Refund Policy
Your membership is backed by Brownstone Research total satisfaction guarantee.
If your membership isn’t everything you expected, simply contact Brownstone Research Customer service team at 888-493-3156 in the first 60 days and they ’ll return 100% of your membership fee, no questions asked. It’s that simple.
Closing Remarks On Jeff Brown’s Executive Confession Presentation
A revolutionary, $217 billion breakthrough in the way we approach medicine is well underway. In the recent market, this industry has already seen gains of 462%, 591%, 1,937%, and 3,239% over the past year.
When you sign up for a 1-year subscription to The Near Future Report and get your report on Jeff’s #1 Precision Medicine Stock of the 2020s…..
You’ll learn how to get in now before disruptive technologies send precision medicine company picks soaring even higher.
By acting today – you’ll save a full $150 off the retail price.
Even better, your special reports are completely FREE with your subscription. And they are mine to keep, even if you cancel!
